0001596783-23-000090.txt : 20230825 0001596783-23-000090.hdr.sgml : 20230825 20230825185212 ACCESSION NUMBER: 0001596783-23-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hopson Ricky CENTRAL INDEX KEY: 0001862832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 231209716 MAIL ADDRESS: STREET 1: CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_169300391930010.xml FORM 4 X0508 4 2023-08-23 0 0001596783 Catalent, Inc. CTLT 0001862832 Hopson Ricky C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 Pres. Clinical Dev Supply Div 0 Common Stock 2023-08-23 4 A 0 789 0 A 21836 D Common Stock 2023-08-24 4 S 0 276 44.56 D 22040 D Received upon the achievement of the fiscal 2021-23 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan. Includes restricted stock units. Shares sold by the reporting person through an automatic "sell to cover" transaction in order to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $44.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of securities reported reflects the acquisition since April 12, 2023 of 480 shares of the Issuer's common stock pursuant to the Issuer's Employee Stock Purchase Plan in transactions exempt from Section 16(b). /s/ Amy Fallone, attorney-in-fact 2023-08-25